Hui-Hui Chen, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, major depressive disorder, and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality
You should discard Mounjaro if you have not used it within 21 days after removing it from the refrigerator
A COA closes that gap by confirming what's actually in the vial, not just what the label claims
There's still this mindset, Once I get this under control, I'll be able to keep it under control, because it's not really a disease